Skip to main content

Fixed Header Call to Actions (Reg Open)


SGLT2 inhibitors in feline diabetes I

21 Mar 2024
Exchange Hall
Advanced Diabetes

An introduction to  SGLT2 inhibitors and the USA experience

  • Know the mechanism of action of SGLT-2 inhibitors and be able to compare with other oral hypoglycaemics and insulin
  • Understand why SGLT2 inhibitors work well in many cases of feline (but not canine) diabetes
  • Understand which cases of feline diabetes mellitus are not suitable for SGLT-2 inhibitors
  • Be aware of the evidence supporting the use of SGLT-2 inhibitors in several USA studies


Dr Ellen Behrend, Professor emerita, Clinical Sciences - Auburn University


Diamond Partner


Ruby Partner


Emerald Partners


Silver Partners


Media Partner